Price $0.29 |
Market Cap
12.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.46
|
P/S
1.2
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
19.9
|
Op. Cash Flow
800
|
FCF
0.0
|
|
Op. Margin
-91.80%
|
Net Margin
-93.40%
|
ROE
-31.20%
|
ROI
-27.10%
|
|
ROA
-21.60%
|
EPS Growth
41.50%
|
Current Ratio
0.9
|
Debt/Equity
14.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $7.65 | - | - | 90.7M | Strong Buy |
| PDL BioPharma Inc (PDLI) | $3.17 | - | - | 355.9M | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.30 | - | - | 48.9M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $1.77 | - | - | 72.7M | Strong Buy |
| TearLab Corp (TEAR) | $0.07 | - | - | 900K | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
